Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells
Authors:
Abstract
Both hypoxia inducible factor 1 (HIF-1) and basic fibroblast growth factor (bFGF) play important roles in tumour angiogenesis. This study was designed to clarify the cooperative effect of these two mediators in induction of vascular endothelial cell growth factor (VEGF) release from breast cancer and probe possible mechanisms involved. Release of VEGF from a breast cancer cell line (T47D) was quantitated by enzyme linked immunosorbent assay (ELISA). Expression of HIF-1 and ERK was assayed using Western blotting. Transient transfection and dual lucifer- ase reporter assay were used to study HIF-1 transactivity. The data showed that hypoxia induced the expression of HIF-1 a protein, the transactivity of HIF-1 and the release of VEGF. bFGF further augmented these hypoxic inductions. The PI3K pathway was required for these processes as demonstrated by application of PI3Kinase inhibitor (LY294002) or mutant construct transfections. In contrast, the MEK1 inhibitor PD98059 showed no effect on either activation of HIF-1 or VEGF release, which is in agreement with our finding that ERK1/2 was not activated by hypoxia. Under hypoxic conditions, bFGF activated the MEK1/ERK pathway. PD98059 blocked the activation of ERK1/2 and suppressed bFGF-induced HIF-1 transactivity, yet the protein expression of HIF-1 α or VEGF release was not affected by PD98059. bFGF augments hypoxia induced VEGF release mainly through the PI3K pathway and partly depending on HIF-1 activity. Elucidation of this mechanism may provide a new target for anti-angiogenesis in cancer therapy.Keywords
This publication has 15 references indexed in Scilit:
- Hypoxic induction of an HIF-1α–dependent bFGF autocrine loop drives angiogenesis in human endothelial cellsBlood, 2006
- In vitro study of HIF‐1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI‐3K/Akt and MEK1/ERK pathwaysThe Journal of Pathology, 2005
- Hypoxia‐inducible factor‐1α is associated with angiogenesis, and expression of bFGF, PDGF‐BB, and EGFR in invasive breast cancerHistopathology, 2005
- Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1–independent MechanismMolecular Biology of the Cell, 2004
- Expression of vascular endothelial growth factor, hypoxia inducible factor 1α, and carbonic anhydrase IX in human tumoursJournal of Clinical Pathology, 2004
- Suppression of Tumor Growth and Angiogenesis in Vivo by a Truncated Form of 24-kd Fibroblast Growth Factor (FGF)-2The American Journal of Pathology, 2004
- Regulation of Vascular Endothelial Growth Factor Expression by Insulin-Like Growth Factor I in Thyroid CarcinomasThe Journal of Clinical Endocrinology & Metabolism, 2003
- Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic SwitchScience, 2002
- A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesisOncogene, 2002
- p42/p44 Mitogen-activated Protein Kinases Phosphorylate Hypoxia-inducible Factor 1α (HIF-1α) and Enhance the Transcriptional Activity of HIF-1Journal of Biological Chemistry, 1999